Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Human Adipose-Derived CD146(+) Stem Cells Increase Life Span of a Muscular Dystrophy Mouse Model More Efficiently than Mesenchymal Stromal Cells

Texto completo
Autor(es):
Gomes, Juliana P. [1] ; Coatti, Giuliana C. [1] ; Valadares, Marcos C. [1] ; Assoni, Amanda F. [1] ; Pelatti, Mayra V. [1] ; Secco, Mariane [1] ; Zatz, Mayana [1]
Número total de Autores: 7
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Inst Biosci, Human Genome & Stem Cell Res Ctr, Rua Matao, 106 Cidade Univ, BR-05508090 Sao Paulo, SP - Brazil
Número total de Afiliações: 1
Tipo de documento: Artigo Científico
Fonte: DNA AND CELL BIOLOGY; v. 37, n. 9, p. 798-804, SEP 2018.
Citações Web of Science: 0
Resumo

Duchenne muscular dystrophy is the most common and severe form of progressive muscular dystrophy. Previous results showed an increased survival in double knockout mice (dko) when treated with adipose-derived CD146(+) cells. In this study, we analyzed the effect of CD146(+) cells compared to mesenchymal stem/stromal cells (MSCs) derived from the same human adipose sample when injected in the dko mouse model without immunosuppression. Both CD146(+) cells and MSCs increased the survival of treated mice when compared to vehicle-injected mice, with a more prominent effect of CD146(+) cells than MSCs. Both CD146(+) cells and MSCs suppressed peripheral blood mononuclear cell proliferation, indicating immunomodulatory properties. Co-culture experiments showed that MSCs have a more inflammatory profile expression, and angiogenesis assay showed that CD146(+) cells can improve blood vessel formation. CD146(+) cells can extend survival of muscular dystrophy mice more efficiently than MSCs, possibly due to immunomodulatory and angiogenic properties. Further investigations focusing on exogenous CD146(+) cell role in vivo will improve cell therapy understanding and effectiveness. (AU)

Processo FAPESP: 13/08028-1 - CEGH-CEL - Centro de Estudos do Genoma Humano e de Células-Tronco
Beneficiário:Mayana Zatz
Linha de fomento: Auxílio à Pesquisa - Centros de Pesquisa, Inovação e Difusão - CEPIDs